Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: final analysis of the randomised, two-cohort PrefHer study
Affiliation auteurs | Affiliation ok |
Titre | Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: final analysis of the randomised, two-cohort PrefHer study |
Type de publication | Journal Article |
Year of Publication | 2016 |
Auteurs | Pivot X., Verma S., Fallowfield L., Mueller V., Lichinitser M., A. Munoz S, Machackova Z., Osborne S., Gligorov J. |
Journal | ANNALS OF ONCOLOGY |
Volume | 27 |
Date Published | OCT 1 |
Type of Article | Meeting Abstract |
ISSN | 0923-7534 |
DOI | 10.1093/annonc/mdw364.65 |